REPL CIK: 1737953

Replimune Group, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
millions USD
FY22:
0
FY23:
0
FY24:
0
FY25:
0
FY26:
0
(positive)
Change from FY22 to FY26
millions USD
FY22:
−118
FY23:
−177
FY24:
−235
FY25:
−262
FY26:
−320
(positive)
Change from FY22 to FY26
millions USD
FY22:
−118
FY23:
−174
FY24:
−215
FY25:
−247
FY26:
−314
(positive)
Change from FY22 to FY26
millions USD
FY22:
−118
FY23:
−174
FY24:
−216
FY25:
−247
FY26:
−314

All amounts in millions USD Data source:SEC EDGAR